Vincent Cottin
#111,469
Most Influential Person Now
Researcher
Vincent Cottin's AcademicInfluence.com Rankings
Vincent Cottincomputer-science Degrees
Computer Science
#4217
World Rank
#4438
Historical Rank
Machine Learning
#760
World Rank
#771
Historical Rank
Artificial Intelligence
#969
World Rank
#987
Historical Rank
Database
#1443
World Rank
#1518
Historical Rank
Download Badge
Computer Science
Vincent Cottin's Degrees
- PhD Computer Science Université Paris Cité
- Masters Computer Science Université Paris Cité
- Bachelors Computer Science Université Paris Cité
Similar Degrees You Can Earn
Why Is Vincent Cottin Influential?
(Suggest an Edit or Addition)Vincent Cottin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. (2013) (2746)
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline (2018) (2039)
- Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. (2014) (1576)
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era (2010) (1265)
- International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia (2009) (891)
- Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. (2019) (875)
- Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity (2005) (856)
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. (2016) (849)
- An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features (2015) (704)
- Pulmonary hypertension due to left heart diseases. (2013) (556)
- Churg‐Strauss syndrome (1999) (530)
- Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension (2017) (454)
- European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis (2010) (430)
- Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome (2009) (400)
- Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. (2008) (340)
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. (2015) (339)
- Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials. (2016) (332)
- Pulmonary hypertension in chronic lung diseases. (2013) (321)
- Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study (2014) (299)
- Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. (2020) (298)
- Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases (2018) (289)
- Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. (2004) (255)
- MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease (2018) (240)
- [Pulmonary hypertension in chronic lung diseases]. (2014) (233)
- The pathogenesis of pulmonary fibrosis: a moving target (2012) (231)
- Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis (2003) (226)
- FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. (2004) (226)
- The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. (2014) (220)
- Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. (1998) (217)
- Spectrum of Fibrotic Lung Diseases. (2020) (207)
- Characterisation of patients with interstitial pneumonia with autoimmune features (2016) (198)
- Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management. (2016) (196)
- Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French-Italian HHT network (2007) (185)
- Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. (2007) (185)
- Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia (Rendu-Osler Disease) (2007) (167)
- Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. (2011) (166)
- Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. (2017) (164)
- Eosinophilic Lung Diseases. (2016) (163)
- Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm (2015) (161)
- Fibrosing interstitial lung diseases: knowns and unknowns (2019) (157)
- TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients (2017) (151)
- Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease (2017) (144)
- The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population (2013) (142)
- Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. (2005) (138)
- Combination therapy: the future of management for idiopathic pulmonary fibrosis? (2014) (134)
- Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease (2010) (133)
- Interstitial lung disease associated with systemic sclerosis (SSc-ILD) (2019) (133)
- The Lung in Rheumatoid Arthritis (2018) (132)
- Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (2017) (130)
- Eosinophilic pneumonias (2005) (129)
- A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective (2017) (128)
- Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis (2015) (127)
- The impact of emphysema in pulmonary fibrosis (2013) (125)
- Lymphangioleiomyomatosis Diagnosis and Management: High‐Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline (2017) (124)
- Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis (2017) (123)
- Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. (2020) (121)
- Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis (2016) (117)
- Idiopathic inflammatory myopathies and the lung (2015) (116)
- Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management (2019) (113)
- Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. (2017) (112)
- Alveolar Hemorrhage in Anti-Basement Membrane Antibody Disease: A Series of 28 Cases (2007) (111)
- Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis (2017) (111)
- Initial dual oral combination therapy in pulmonary arterial hypertension (2016) (109)
- Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events (2014) (107)
- Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis? (2012) (107)
- Severe hematologic complications after lung transplantation in patients with telomerase complex mutations. (2015) (106)
- Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials (2013) (104)
- Cross‐talk between Staphylococcus aureus leukocidins‐intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome‐dependent manner (2012) (104)
- ANCA-associated lung fibrosis: analysis of 17 patients. (2008) (102)
- Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis (2009) (99)
- Restricted Localization of the TNF Receptor CD120a to Lipid Rafts: A Novel Role for the Death Domain1 (2002) (98)
- Respiratory bronchiolitis in smokers with spontaneous pneumothorax. (1998) (94)
- The natural history of progressive fibrosing interstitial lung diseases (2020) (93)
- Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis (2015) (91)
- Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study (2018) (91)
- Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial (2012) (89)
- Predictors of progression in systemic sclerosis patients with interstitial lung disease (2020) (87)
- Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension (2017) (87)
- Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association. (2007) (87)
- Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis (2012) (86)
- Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation (2011) (85)
- TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study (2018) (85)
- Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures (2016) (85)
- Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. (2011) (85)
- CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab (2015) (84)
- Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (2016) (83)
- Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study (2015) (82)
- Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents (2014) (82)
- Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis. (2014) (81)
- Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome (2016) (80)
- Alveolar hemorrhage in vasculitis: primary and secondary. (2011) (80)
- Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study. (2019) (80)
- Cough in idiopathic pulmonary fibrosis (2016) (79)
- Interstitial Lung Disease in Idiopathic Inflammatory Myopathy. (2010) (78)
- Pulmonary hypertension associated with benfluorex exposure (2012) (78)
- Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models. (2015) (78)
- Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good (2012) (77)
- Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients (2012) (76)
- Pulmonary alveolar proteinosis. (2004) (76)
- Anti‐IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss): Data on Seventeen Patients (2016) (76)
- Chronic eosinophilic pneumonia after radiation therapy for breast cancer (2004) (76)
- Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study) (2020) (75)
- Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis. (2019) (75)
- Cryptogenic Organizing Pneumonia (2004) (73)
- Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep. (2007) (72)
- The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia (2013) (72)
- Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines (2014) (72)
- Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study (2017) (71)
- Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). (2016) (70)
- Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment (2014) (69)
- Interstitial Lung Disease Associated with Anti-PM/Scl or Anti-Aminoacyl-tRNA Synthetase Autoantibodies: A Similar Condition? (2010) (69)
- Interstitial lung disease: are we missing formes frustes of connective tissue disease? (2006) (69)
- Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study (2018) (68)
- Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events (2014) (68)
- Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis (2013) (68)
- Right isovolumic contraction velocity predicts survival in pulmonary hypertension. (2013) (65)
- Different phenotypes in dermatomyositis associated with anti-MDA5 antibody (2020) (65)
- Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis (2014) (64)
- Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis (2017) (63)
- Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature. (2017) (62)
- Idiopathic interstitial pneumonias with connective tissue diseases features: A review (2016) (62)
- TOSCA – first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex (2014) (60)
- The syndrome of combined pulmonary fibrosis and emphysema. (2009) (59)
- Combined pulmonary fibrosis and emphysema in connective tissue disease (2012) (58)
- Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study (2017) (58)
- Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis (2017) (58)
- Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis (2017) (57)
- Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases (2019) (56)
- “ERS/ATS Task Force onUndifferentiated Forms of CTD-ILD”. An official European RespiratorySociety/American Thoracic Society research statement: interstitial pneumonia withautoimmunefeatures (2015) (55)
- Pulmonary alveolar proteinosis (2019) (55)
- Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Series of 47 Western Patients (2014) (54)
- Portopulmonary hypertension in the current era of pulmonary hypertension management. (2020) (54)
- The Lung in Hereditary Hemorrhagic Telangiectasia (2017) (53)
- Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry (2018) (53)
- Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes (2012) (53)
- Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema (2009) (52)
- Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis. (2014) (52)
- Triple therapy in idiopathic pulmonary fibrosis: an alarming press release (2012) (50)
- Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension (2018) (50)
- A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials (2015) (50)
- [French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. From the National Reference and the Competence centers for rare diseases and the Société de Pneumologie de Langue Française]. (2013) (50)
- Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis (2017) (49)
- Tracheobronchial Stenoses in Granulomatosis With Polyangiitis (Wegener's) (2015) (49)
- Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study. (2019) (49)
- Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial (2018) (48)
- Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study (2017) (47)
- Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension (2015) (47)
- Persistent airflow obstruction in asthma of patients with Churg–Strauss syndrome and long‐term follow‐up (2009) (47)
- Significance of connective tissue diseases features in pulmonary fibrosis (2013) (46)
- Combined pulmonary fibrosis and emphysema: an experimental and clinically relevant phenotype. (2005) (46)
- Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group. (2014) (46)
- CT Imaging Assessment of Response to Treatment in Chronic Pulmonary Aspergillosis. (2016) (45)
- Late-Onset Sarcoidosis: A Comparative Study (2012) (44)
- Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo. (1998) (44)
- Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept. (2005) (44)
- Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness (2018) (44)
- Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension – clinical management (2013) (43)
- Alveolar Hemorrhage in Vasculitis (Primary and Secondary) (2018) (43)
- Rare lung disease and orphan drug development. (2013) (43)
- Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastases. (2006) (43)
- Usual interstitial pneumonia end-stage features from explants with radiologic and pathological correlations. (2015) (42)
- Parenchymal lung involvement in adult-onset Still disease (2016) (41)
- Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine (2016) (41)
- Interstitial Lung Disease Evaluation: Detecting Connective Tissue Disease (2015) (40)
- Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension. (2021) (40)
- Infections opportunistes et sarcoïdose (2004) (40)
- Alveolar type II cells isolated from pulmonary adenocarcinoma: a model for JSRV expression in vitro. (2007) (40)
- Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease–Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities (2019) (40)
- Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation (2020) (39)
- [Combined apical emphysema and basal fibrosis syndrome (emphysema/fibrosis syndrome): CT imaging features and pulmonary function tests]. (2009) (39)
- 4D time‐resolved magnetic resonance angiography for noninvasive assessment of pulmonary arteriovenous malformations patency (2010) (39)
- French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Full-length version. (2022) (39)
- Diagnostic Likelihood Thresholds that Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. (2019) (38)
- Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis (2018) (38)
- The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis (2013) (38)
- Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases (2019) (38)
- Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review (2015) (38)
- Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis (2019) (37)
- Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registry. (2018) (37)
- Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes (2019) (37)
- Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey (2020) (37)
- Interstitial Pneumonia With Autoimmune Features (IPAF) (2019) (37)
- Long-term follow-up in 12 children with pulmonary arteriovenous malformations: confirmation of hereditary hemorrhagic telangiectasia in all cases. (2007) (36)
- Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study (2021) (36)
- Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study (2020) (36)
- Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan (2010) (36)
- Churg-Strauss syndrome presenting with acute myocarditis and cardiogenic shock. (2012) (36)
- Hypereosinophilic obliterative bronchiolitis: a distinct, unrecognised syndrome (2012) (35)
- Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis. (2019) (35)
- Connective tissue diseases, multimorbidity and the ageing lung (2016) (35)
- Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor. (2019) (34)
- Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis (2018) (34)
- Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty (2016) (34)
- Right-to-left shunt with hypoxemia in pulmonary hypertension (2009) (34)
- Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey (2014) (32)
- Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease (2020) (32)
- Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial (2021) (32)
- Eosinophilic lung diseases. (2012) (31)
- Cough-Induced Intercostal Lung Herniation Requiring Surgery: Report of a Case (2006) (31)
- Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation (2018) (31)
- Interstitial lung disease (2013) (30)
- Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry. (2014) (30)
- In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography (2020) (30)
- Phosphorylation of the Tumor Necrosis Factor Receptor CD120a (p55) Recruits Bcl-2 and Protects against Apoptosis* (2001) (30)
- A systematically derived exposure assessment instrument for Chronic Hypersensitivity Pneumonitis. (2020) (29)
- Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy (2015) (29)
- Telomerase activation in a model of lung adenocarcinoma (2006) (29)
- Conditions associated with severe carbon monoxide diffusion coefficient reduction. (2011) (29)
- A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report (2019) (29)
- Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension (2020) (28)
- Rituximab for auto-immune alveolar proteinosis, a real life cohort study (2018) (28)
- Smoking-related lung diseases: a clinical perspective (2010) (28)
- Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality. (2019) (28)
- Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis (2020) (28)
- Management of idiopathic pulmonary fibrosis in France: a survey of 1244 pulmonologists. (2012) (27)
- Unclassified or unclassifiable interstitial lung disease: confusing or helpful disease category? (2013) (27)
- Lung Diseases in Inflammatory Myopathies (2019) (27)
- Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis: Results of two 52-week, Phase III, randomized, placebo-controlled trials (INPULSIS™) (2015) (26)
- Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial. (2021) (26)
- [Opportunistic infections and sarcoidosis]. (2004) (26)
- Combined pulmonary fibrosis and emphysema: bad and ugly all the same? (2017) (26)
- Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities. (2021) (26)
- Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy (2009) (26)
- Pneumopathies interstitielles diffuses idiopathiques (2004) (25)
- Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosis. (2002) (25)
- IPF, comorbidities and management implications. (2015) (25)
- Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study. (2022) (25)
- Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis. (2019) (25)
- External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry (2021) (25)
- S11 Pirfenidone Post-authorisation Safety Registry (passport)–interim Analysis Of Ipf Treatment (2014) (25)
- Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases (2021) (24)
- Epidemiology, clinical picture and long‐term outcomes of FIP1L1‐PDGFRA‐positive myeloid neoplasm with eosinophilia: Data from 151 patients (2020) (24)
- Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study (2018) (24)
- Effect of baseline emphysema on reduction in FVC decline with nintedanib in the INPULSIS™ trials (2014) (24)
- Urinary eosinophil-derived neurotoxin in Churg-Strauss syndrome. (1995) (24)
- French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides) (2020) (23)
- Clinical Genetics of Prolidase Deficiency: An Updated Review (2020) (23)
- Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial. (2019) (23)
- [Diffuse idiopathic interstitial pneumonias. International multidisciplinary consensus classification by the American Thoracic Society and the European Respiratory Society, principal clinico-pathological entities, and diagnosis]. (2004) (23)
- L5. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss). (2013) (22)
- Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey (2019) (22)
- A RANDOMIZED PLACEBO CONTROLLED TRIAL ASSESSING THE EFFICACY AND SAFETY OF ETANERCEPT IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) (2005) (22)
- Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort (2016) (22)
- Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients. (2019) (22)
- Late Breaking Abstract - Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension: results from the randomised controlled RACE study (2019) (22)
- Pulmonary arterial hypertension in idiopathic inflammatory myopathies (2016) (22)
- RISE-IIP: Riociguat for the treatment of pulmonary hypertension associated with idiopathic interstitial pneumonia (2017) (21)
- Lung histopathology of non‐infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation (2018) (21)
- Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation (2020) (21)
- Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study. (2020) (21)
- Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study) (2021) (21)
- Mitomycin-Induced Pulmonary Veno-Occlusive DiseaseCLINICAL PERSPECTIVE (2015) (21)
- Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis (2019) (21)
- Whole exome sequencing in three families segregating a pediatric case of sarcoidosis (2018) (20)
- [French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary]. (2017) (20)
- Late CF caused by homozygous IVS8-5T CFTR polymorphism (2005) (20)
- Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: Correlations between computed tomography findings and cerebral complications (2018) (20)
- Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end (2018) (19)
- Many Faces of Bronchiolitis and Organizing Pneumonia (2016) (19)
- French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Short-length version. (2017) (19)
- Serum and pulmonary uric acid in pulmonary arterial hypertension (2021) (19)
- Pulmonary Varix Mimicking Pulmonary Arteriovenous Malformation in a Patient with Turner Syndrome (2005) (19)
- French recommendations for the management of systemic sclerosis (2021) (19)
- Variability in Global Prevalence of Interstitial Lung Disease (2021) (18)
- Burden of Illness and Quality of Life in Tuberous Sclerosis Complex: Findings From the TOSCA Study (2020) (18)
- Outcomes following decline in forced vital capacity in patients with idiopathic pulmonary fibrosis: Results from the INPULSIS and INPULSIS-ON trials of nintedanib. (2019) (18)
- The Clinical Relevance of Antifibrillarin (anti‐U3‐RNP) Autoantibodies in Systemic Sclerosis (2017) (18)
- Review of IPF diagnosis and management recommendations in Europe. (2013) (18)
- Cisplatin-induced hyponatremia and renal sodium wasting. (1995) (18)
- Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases. (2020) (18)
- Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials (2019) (18)
- A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension (2015) (18)
- Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. (2022) (18)
- Patients', relatives', and practitioners' views of pulmonary arterial hypertension: A qualitative study. (2016) (17)
- Translation and validation of the King’s Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch (2017) (17)
- Pragmatic prognostic approach of rheumatoid arthritis-associated interstitial lung disease (2010) (17)
- [Pulmonary arterial hypertension in connective tissue disease]. (2006) (17)
- Results of a phase 2 study of GLPG1205 for idiopathic pulmonary fibrosis (PINTA) (2021) (17)
- The Respiratory System in Autoimmune Vascular Diseases (2018) (17)
- Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water (2013) (16)
- The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis (2021) (16)
- Spectral Photon-Counting CT Technology in Chest Imaging (2021) (16)
- Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation (2020) (16)
- Symptomatic muscular sarcoidosis (2018) (16)
- Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study (2019) (16)
- Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension (2016) (16)
- A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT (2019) (15)
- Occupational hypersensitivity pneumonitis in a baker: a new cause. (2014) (15)
- Risk factors for disease progression in idiopathic pulmonary fibrosis (2019) (15)
- Respiratory failure with diffuse bronchiectases and cryoglobulinaemia (2008) (15)
- Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease (2019) (15)
- Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups (2018) (15)
- SFTPC mutations in patients with familial pulmonary fibrosis: combined with emphysema? (2011) (15)
- The safety and tolerability of nintedanib in the treatment of idiopathic pulmonary fibrosis (2017) (15)
- Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial (2021) (15)
- Air travel and incidence of pneumothorax in lymphangioleiomyomatosis (2018) (15)
- Presence of Kidney Disease as an Outcome Predictor in Patients with Pulmonary Arterial Hypertension (2018) (15)
- Of fi cial American Thoracic Society / Japanese Respiratory Society Clinical Practice Guidelines : Lymphangioleiomyomatosis Diagnosis and Management (2016) (15)
- Clinical Characteristics of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex (2019) (15)
- Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project (2020) (14)
- Global effort against rare and orphan diseases (2012) (14)
- Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response (2011) (14)
- Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey (2015) (14)
- Nintedanib: a new treatment for idiopathic pulmonary fibrosis (2015) (14)
- Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened (2016) (14)
- Clonal expansion of T cells in patients with eosinophilic lung disease (2011) (14)
- Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy? (2017) (14)
- Milestones in lymphangioleiomyomatosis research (2011) (14)
- Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP) (2019) (14)
- Infiltrative lung diseases in pregnancy. (2011) (14)
- Alveolar macrophages from sheep naturally infected by visna-maedi virus contribute to IL-8 production in the lung. (1997) (13)
- Renal Manifestations of Tuberous Sclerosis Complex: Key Findings From the Final Analysis of the TOSCA Study Focussing Mainly on Renal Angiomyolipomas (2020) (13)
- Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial (2018) (13)
- Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer (2020) (13)
- Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement. (2022) (13)
- [Infliximab treatment for chronic sarcoidosis--a case series]. (2010) (12)
- A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis. (2016) (12)
- Should patients with lymphangioleiomyomatosis undergo screening for meningioma? (2004) (12)
- Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry (2018) (12)
- Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis (2021) (12)
- Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension (2018) (12)
- Mesenchymal cystic hamartoma of the lung in Cowden's disease. (2003) (12)
- Forme pegylée de l'interféron alpha 2b et pneumopathies interstitielles diffuses (2002) (11)
- Validation of multidisciplinary diagnosis in IPF. (2018) (11)
- Vein Diameter on Unenhanced Multidetector CT Predicts Reperfusion of Pulmonary Arteriovenous Malformation after Embolotherapy (2016) (11)
- Syndrome of pleural and retrosternal “bridging” fibrosis and retroperitoneal fibrosis in patients with asbestos exposure (2009) (11)
- Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics (2013) (11)
- Pulmonary alveolar proteinosis following cryptococcal meningitis: a possible cause? (2018) (11)
- Treatment Patterns and Use of Resources in Patients With Tuberous Sclerosis Complex: Insights From the TOSCA Registry (2019) (11)
- Sarcoidosis from bench to bedside: a state-of-the-art series for the clinician (2012) (11)
- Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype (2020) (11)
- Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients (2020) (11)
- [Interstitial lung disease-associated with amyopathic dermatomyositis and anti-MDA5 autoantibodies]. (2014) (11)
- Phenotyping chronic pulmonary aspergillosis by cluster analysis (2015) (11)
- Diurnal variation in forced vital capacity in patients with fibrotic interstitial lung disease using home spirometry (2020) (11)
- BPA and Riociguat for the Management of Inoperable CTEPH: Results of the Extension Study Following the RACE Randomized Controlled Trial (RCT) (10)
- Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database (2019) (10)
- Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody–associated Vasculitis-related Bronchiectasis: Data from 61 Patients (2019) (10)
- [Induced interstitial pneumonitis: role of pegylated interferon alpha 2b]. (2002) (10)
- Exogenous Lipid Pneumonia (2006) (10)
- [Combined pulmonary fibrosis and emphysema]. (2014) (10)
- Update on bioagent therapy in sarcoidosis (2010) (10)
- Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease (2020) (10)
- Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America (2018) (10)
- Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: follow-up and pathophysiologic considerations. (2007) (10)
- [Interstitial lung disease and anti-TNF-alpha therapy in rheumatoid arthritis: Two different patterns?]. (2010) (10)
- Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. (2022) (9)
- Isolated Recurrent Pleuritis Revealing Familial Mediterranean Fever in Adulthood (2009) (9)
- Should Patients With Interstitial Lung Disease Be Seen by Experts? (2018) (9)
- Characteristics and long-term outcomes of pulmonary veno-occlusive disease induced by Mitomycin-C. (2020) (9)
- Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort. (2021) (9)
- Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult (2020) (9)
- Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis (2018) (9)
- [Treatment of pulmonary fibrosis]. (2002) (9)
- Health economic evaluation in idiopathic pulmonary fibrosis in France (2018) (9)
- [Iatrogenic drug-induced bronchospasm, cough, and bronchiolitis. Etiologic and physiopathologic aspects]. (1996) (9)
- Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis (2019) (9)
- Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss (2021) (9)
- [Idiopathic diffuse interstitial lung disease]. (2000) (9)
- Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here? (2021) (9)
- Combined Pulmonary Fibrosis and Emphysema Syndrome in a Patient Age 28 Years with Severe Systemic Sclerosis (2011) (9)
- Professional Exposure to Goats Increases the Risk of Pneumonic-Type Lung Adenocarcinoma: Results of the IFCT-0504-Epidemio Study (2011) (9)
- Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study. (2021) (9)
- Nonspecific interstitial pneumonia: time to be more specific? (2016) (9)
- Pulmonary arterial hypertension in heroin users. (2016) (8)
- Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome (2015) (8)
- [Churg-Strauss syndrome]. (2003) (8)
- COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study (2022) (8)
- Interstitial Pulmonary Amyloidosis (2005) (8)
- Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in France (2020) (8)
- Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA) (2021) (8)
- [Pulmonary manifestations of hereditary hemorrhagic telangiectasia]. (2006) (8)
- The threat in chronic lung diseases: acute exacerbations (2017) (8)
- Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody (2015) (8)
- Hemodynamic response to treatment and outcome in pulmonary hypertension associated with interstitial lung disease versus pulmonary arterial hypertension in systemic sclerosis. (2020) (8)
- Interstitial lung disease: new challenges and evolving phenotypes (2010) (7)
- Assessment of T-cell polarization on the basis of surface marker expression: diagnosis and potential therapeutic implications in lymphocytic variant hypereosinophilic syndrome. (2020) (7)
- A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey (2018) (7)
- [Idiopathic pulmonary fibrosis]. (2008) (7)
- The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis (2018) (7)
- Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis (2018) (7)
- Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial (2022) (7)
- Mediastinal lymphangioma in an adult. (2018) (7)
- Screening for lung cancer and idiopathic pulmonary fibrosis: killing two birds with one stone. (2014) (7)
- Healthcare pathway and patients' expectations in pulmonary fibrosis (2017) (7)
- Near-fatal haemorrhage from pulmonary arteriovenous malformation in HHT with increased cardiac output (2009) (7)
- Tuberous sclerosis complex for the pulmonologist (2021) (7)
- Eosinophilic granulomatosis with polyangiitis : Future therapies (2013) (7)
- Subclinical interstitial lung disease: no place for crackles? (2012) (7)
- Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry (2021) (7)
- Ambivalence of CD4 lymphocytopenia in sarcoidosis. (2003) (7)
- Lung-limited or lung-dominant variant of Eosinophilic Granulomatosis with Polyangiitis. (2020) (7)
- Coexisting relapsing polychondritis and sarcoidosis: an unusual association (2010) (7)
- [Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020]. (2020) (7)
- Monoallelic germline ATM mutation and organising pneumonia induced by radiation therapy to the breast (2016) (7)
- Phenotype and outcome of PAH patients carrying a TBX4 mutation. (2020) (7)
- The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis (2019) (7)
- Drug-induced interstitial lung disease (2022) (7)
- Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden (2021) (7)
- Rare (pulmonary) disease day: “feeding the breath, energy for life!” (2015) (7)
- Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases (2022) (6)
- Practical Issues and Challenges in Idiopathic Pulmonary Fibrosis (2013) (6)
- Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to? (2015) (6)
- Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses (2021) (6)
- Determinants of survival after lung transplantation in telomerase‐related gene mutation carriers: A retrospective cohort (2021) (6)
- Clinical Trials in IPF: What Are the Best Endpoints? (2018) (6)
- [Pulmonary MALT lymphoma revealing AIDS]. (2006) (6)
- Lymphangioléiomyomatose pulmonaire [Lymphangioleiomyomatosis] (2010) (6)
- Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France (2019) (6)
- Lung progenitors from lambs can differentiate into specialized alveolar or bronchiolar epithelial cells (2013) (6)
- French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary. (2017) (6)
- The Challenge of Acute Exacerbation of Pulmonary Fibrosis (2011) (6)
- European Respiratory roadmap. Recommendations for the future of respiratory medicine. (2011) (6)
- [Nonspecific interstitial pneumonitis: a new anatomoclinical entity among idiopathic diffuse interstitial pneumonias]. (2001) (6)
- Idiopathic eosinophilic pneumonias (2011) (6)
- The changing picture of patients with pulmonary arterial hypertension (PAH) in France (2011) (6)
- The progressive fibrotic phenotype in current clinical practice (2021) (6)
- Safety of right heart catheterization for pulmonary hypertension in very elderly patients (2018) (6)
- [Pulmonary hypertension due to left heart diseases]. (2018) (6)
- Pulmonary hypertension in patients with idiopathic pulmonary fibrosis (2012) (6)
- Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model". (2016) (6)
- Insights into idiopathic pulmonary fibrosis in the real world (2015) (6)
- Pirfenidone post-authorization safety registry (PASSPORT) update (2015) (6)
- Interstitial pneumonia with autoimmune features: challenges and controversies (2021) (6)
- [Urinary incontinence due to chronic cough in interstitial lung disease]. (2009) (5)
- AB0007 Shared genetic predisposition in rheumatoid arthritis–interstitial lung disease and familial pulmonary fibrosis (2017) (5)
- The Burden of Progressive-Fibrosing Interstitial Lung Diseases (2022) (5)
- TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex (2021) (5)
- Interstitial Lung Disease Associated with Adult Niemann-Pick Disease Type B (2017) (5)
- [Lipid pneumonia]. (2007) (5)
- Epidemiology and real-life experience in progressive pulmonary fibrosis (2022) (5)
- Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases (2022) (5)
- Reduction in disease progression with nintedanib in the INPULSIS™ trials (2014) (5)
- Concurrence of 1- and 3-Min Sit-to-Stand Tests with the 6-Min Walk Test in Idiopathic Pulmonary Fibrosis (2021) (5)
- Impact of Initial Triple Combination Therapy on Long-Term Survival in Pulmonary Arterial Hypertension (PAH) (2019) (5)
- [Alveolar hemorrhages: observation]. (2006) (5)
- Interstitial lung diseases associated with mutations of poly(A)‐specific ribonuclease: A multicentre retrospective study (2022) (5)
- A French National Prospective Cohort of Patients with Idiopathic Pulmonary Fibrosis (IPF): Demographic Characteristics. (2009) (5)
- Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics (2021) (5)
- Cancer incidence in patients with pre-capillary pulmonary hypertension. (2019) (5)
- Survival improved in systemic sclerosis associated pulmonary arterial hypertension patients aged 70 years or less over the period 2006-2017 in France. (2019) (5)
- Digital Lung Auscultation: Will Early Diagnosis of Fibrotic Interstitial Lung Disease Become a Reality? (2019) (5)
- Spontaneous pneumomediastinum associated with pneumorachis. (2014) (5)
- Eosinophilic pneumonia in a patient with breast cancer: idiopathic or not? (2006) (5)
- Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal? (2020) (5)
- Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover. (2021) (5)
- [French practical guidelines for the diagnosis and management of IPF - 2021 update, short version]. (2022) (5)
- [Pulmonary vascular manifestations in hereditary hemorrhagic telangiectasia]. (2005) (5)
- Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective (2016) (5)
- Accuracy Of A Clinical Diagnosis Of Idiopathic Pulmonary Fibrosis: A Study Of 275 Pulmonologists From 54 Countries (2017) (5)
- Clinical Genetics for the Pulmonologist: Introduction (2005) (5)
- Clinical highlights from the 2011 ERS Congress in Amsterdam (2012) (5)
- Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trial. (2020) (5)
- Selected clinical highlights from the 2010 ERS Congress in Barcelona (2011) (5)
- Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency (2014) (5)
- [Pulmonary lymphangioleiomyomatosis: From pathogenesis to management]. (2016) (5)
- [French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Short-length version]. (2017) (4)
- [Genetic pulmonary fibrosis]. (2014) (4)
- Effect of nintedanib on blood biomarkers in patients with IPF in the INMARK trial (2019) (4)
- [Pulmonary sarcoidosis: Diagnostic challenges]. (2011) (4)
- A dynamic prognostic model to predict survival and determine treatment goals in pulmonary arterial hypertension (PAH): the EFORT study (2019) (4)
- Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema (CPFE): A Systematic Review. (2020) (4)
- Spectrum of Fibrotic Lung Diseases. Reply. (2020) (4)
- [French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. 2017 update. Full-length update]. (2017) (4)
- [Relapsing pneumothorax in a young woman, revealing lymphangioleiomyomatosis]. (2010) (4)
- Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases (2014) (4)
- Multidisciplinary team dedicated to suspected heritable pulmonary fibrosis (2018) (4)
- Lung Involvement in Rheumatic Disease: Introduction (2015) (4)
- Celiac disease revealed by diffuse alveolar hemorrhage and heart block (2006) (4)
- Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World (2021) (4)
- The European Respiratory Review: mature, expanding and targeting new challenges (2013) (4)
- Diffuse bronchiectasis and airflow obstruction in granulomatosis with polyangiitis (2018) (4)
- 015 Anti-IgE monoclonal antibody (omalizumab) in refractory and relapsing eosinophilic granulomatosis with polyangiitis: data from 17 patients (2016) (4)
- Effect of baseline corticosteroid medication on reduction in FVC decline with nintedanib (2015) (4)
- Pulmonary hypertension therapy and COPD: still many questions to be answered. (2009) (4)
- Future perspectives on rare pulmonary diseases and rare presentations of common disorders (2013) (4)
- [Diffuse systemic sclerosis after occupational exposure to trichloroethylene and perchloroethylene]. (2009) (4)
- [Combined pulmonary fibrosis and emphysema]. (2014) (4)
- SARCOIDOSIS DIAGNOSED IN THE ELDERLY: A CASE CONTROL STUDY. (2020) (4)
- The yin and yang of idiopathic pulmonary fibrosis (2017) (4)
- [Idiopathic pulmonary fibrosis]. (2007) (4)
- Selected clinical highlights from the 2012 ERS congress in Vienna (2012) (4)
- Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review (2020) (4)
- Safety and efficacy of pirfenidone in patients with lung fibrosis and TERT mutation (2016) (4)
- [Renal AA amyloidosis secondary to bronchiectasis: a report of two cases (including one with Mounier-Kuhn syndrome)]. (2004) (4)
- International Guidelines for the Diagnosis and Telangiectasia Management of Hereditary Hemorrhagic (4)
- Late Breaking Abstract - Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry (2017) (4)
- An Important Step Forward, but Still a Way to Go. (2016) (4)
- Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem (2017) (4)
- Who and what should we rely on in early diagnosis of idiopathic pulmonary fibrosis? (2013) (4)
- Treatment with nintedanib in patients with pleuroparenchymal fibroelastosis (2017) (4)
- Should We Screen for Pulmonary Hypertension at the Initial Evaluation of Idiopathic Pulmonary Fibrosis? (2013) (4)
- Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary Fibrosis (2020) (3)
- Idiopathic non-necrotizing eosinophilic vasculitis limited to the lung: Part of a complex spectrum. (2020) (3)
- The case of methotrexate and the lung: Dr Jekyll and Mr Hyde (2021) (3)
- Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use (2021) (3)
- Lung Biopsy in Interstitial Lung Diseases: There Is More than One Way to Cook an Egg (2018) (3)
- Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity (2019) (3)
- Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases (2022) (3)
- Pneumopathies interstitielles diffuses (2004) (3)
- Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. (2019) (3)
- Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience (2014) (3)
- The world of rare interstitial lung diseases (2023) (3)
- Late Breaking Abstract - Phase II trial of pirfenidone in patients with progressive fibrosing unclassifiable ILD (uILD) (2019) (3)
- The challenge of criteria for interstitial pneumonia with autoimmune features. (2017) (3)
- When to stop in the quest of formes frustes of connective tissue disease? (2007) (3)
- Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort (2021) (3)
- Hierarchical phosphorylation of the TNF-alpha receptor, TNF-R1, by p42Mapk/Erk at basic Pro-directed kinase sites. (2005) (3)
- Evolution from hypereosinophilic bronchiolitis to eosinophilic granulomatosis with polyangiitis following COVID-19: a case report. (2021) (3)
- A 12-week combination of clarithromycin and prednisone compared to a 24-week prednisone alone treatment in cryptogenic and radiation-induced organizing pneumonia (2018) (3)
- Computed tomography assessment of response to treatment in chronic pulmonary aspergillosis (2015) (3)
- Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort (2021) (3)
- Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry (2016) (3)
- Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives (2022) (3)
- [Respiratory function surveillance during prolonged treatment with low-dose methotrexate]. (1997) (3)
- Genetic testing in idiopathic interstitial pneumonia (2015) (3)
- Review of idiopathic pulmonary fibrosis diagnosis and management recommendations in Europe (2013) (3)
- Orphan Lung Diseases from Definition to Organisation of Care (2015) (3)
- Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration (2018) (3)
- Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France (2021) (3)
- Joint CHEST-SGP Congress 2017. Basel, Switzerland, 7-9 June 2017: Abstracts (2017) (3)
- Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association (2016) (3)
- Angiotensin Receptor Blockers and Subclinical Interstitial Lung Disease: The MESA Study. (2019) (3)
- Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography (2022) (3)
- Diurnal variation in forced vital capacity in patients with fibrotic interstitial lung disease using home spirometry: the DIVA study (2019) (3)
- Nintedanib in patients with chronic fibrosing Interstitial lung diseases with progressive phenotype: the INBUILD trial* (2019) (3)
- Integration and application of clinical practice guidelines for the diagnosis of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. (2022) (3)
- Pulmonary fibrosis: “idiopathic” is not “cryptogenic” (2019) (3)
- Effect of nintedanib in patients with limited and extensive systemic sclerosis-associated interstitial lung disease (SSc-ILD): data from the SENSCIS trial (2020) (3)
- Syndrome of pleural and retrosternal “bridging” fibrosis and retroperitoneal fibrosis in patients with asbestos exposure (2007) (3)
- Combined Pulmonary Emphysema And Fibrosis In Connective Tissue Disease (2010) (2)
- [French practical guidelines for the diagnosis and management of IPF - 2021 update, full version]. (2022) (2)
- Therapeutic benefit of ivacaftor in late cystic fibrosis caused by homozygous IVS8-5T CFTR polymorphism. (2017) (2)
- Pleuroparenchymal fibroelastosis: so many unmet needs (2022) (2)
- IC4: a new combined predictive index of mortality in idiopathic pulmonary fibrosis. (2021) (2)
- POSTER VIEWING SESSION - EMBRYOLOGY (2011) (2)
- Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease (2015) (2)
- Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial (2020) (2)
- Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis (2022) (2)
- French Vasculitis Study Group recommendations for the management of COVID-19 vaccination and prophylaxis in patients with systemic vasculitis (2021) (2)
- Pirfenidone Post-Authorization Safety Registry (PASSPORT): Update and Concomitant Use of NAC and/or Corticosteroids (2015) (2)
- Pulmonary Vein Varices Are Syndromic Features in Turner Syndrome (2017) (2)
- Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report. (2009) (2)
- Preliminary results of the French national prospective cohort on IPF (2011) (2)
- Diagnostic approach of fibrosing interstitial lung diseases of unknown origin (2020) (2)
- Idiopathic pulmonary fibrosis: time for greater expectations? (2018) (2)
- Characteristics of Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) in the INBUILD Trial of Nintedanib (2019) (2)
- Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis (2022) (2)
- Contribution Of Mutations In Genes Encoding Proteins Of The Surfactant Metabolism To Idiopathic Interstitial Pneumonia And Idiopathic Pulmonary Fibrosis In A Cohort Of 265 Families (2016) (2)
- Combined pulmonary fibrosis and emphysema in alpha-1-antitrypsin deficiency. (2021) (2)
- Pulmonary Manifestations of Systemic Diseases (2019) (2)
- [Autoimmune hepatitis associated with multiple sclerosis]. (2004) (2)
- INITIAL TREATMENT COMBINATION WITH MACITENTAN AND TADALAFIL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE OPTIMA STUDY (2019) (2)
- Tolerance and efficacy of antifibrotic treatments in IPF patients carriying telomere related gene mutations (2019) (2)
- Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides) (2021) (2)
- [French recommendations for idiopathic pulmonary fibrosis: Oriented toward practice]. (2013) (2)
- [Syndrome of combined pulmonary fibrosis and emphysema: understanding the functional profile]. (2013) (2)
- Interstitial pneumonia with autoimmune features: An update. (2018) (2)
- Diagnostic value of serum VEGF-D in consecutive patients with lymphangioleiomyomatosis (2011) (2)
- Adherence to home spirometry among patients with IPF: results from the INMARK trial (2019) (2)
- GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial (2022) (2)
- Contribution of mutations in genes of the surfactant system to idiopathic interstitial pneumonia (IIP) (2018) (2)
- A call for evidence in connective tissue diseases-associated interstitial lung disease. (2021) (2)
- Women and interstitial lung diseases (2003) (2)
- Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition? (2022) (2)
- Sjögren disease, not Sjögren's: comment on the article by Baer and Hammitt (2021) (2)
- Finger clubbing and altered carbon monoxide transfer capacity in cannabis smokers (2008) (2)
- Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry (2017) (2)
- Pulmonary Vascular Disorders in Hereditary Hemorrhagic Telangiectasia (2012) (2)
- Home Spirometry as a Primary Endpoint in Clinical Trials: Sensitivity Analyses of a Randomized Controlled Trial of Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease (UILD) (2020) (2)
- [Unusual pulmonary presentation of lysinuric protein intolerance]. (2010) (2)
- Oxidant-antioxidant imbalance in the experimental interstitial lung disease induced in sheep by visna-maedi virus. (1996) (2)
- The TOSCA Registry for Tuberous Sclerosis—Lessons Learnt for Future Registry Development in Rare and Complex Diseases (2019) (2)
- Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey (2017) (2)
- Clinical impact of TERT somatic mutation in telomerase-related gene mutation carriers after lung transplantation. (2022) (1)
- RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial (2021) (1)
- Diagnosis of Idiopathic Pulmonary Fibrosis An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Executive Summary (2018) (1)
- P-700 Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis in patients with non-small cell lung cancer: A prospective study (2005) (1)
- Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions (2020) (1)
- Development and Testing of a Formula for Predicting Emphysema Extent in Patients with Idiopathic Pulmonary Fibrosis (2019) (1)
- Agreement Between Pulmonologists For The Diagnosis Of Interstitial Lung Disease: A Study Of 275 Pulmonologists From 54 Countries (2017) (1)
- The European Respiratory Review: farewell from the editor with confidence for the future (2015) (1)
- Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm (2022) (1)
- Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies (2022) (1)
- Combined Pulmonary Fibrosis and Emphysema with Associated Pulmonary Hypertension: Characteristics and Prognostic Determinants. (2009) (1)
- Corrigendum to: "Portopulmonary hypertension in the current era of pulmonary hypertension management" [J Hepatol (2020);73:130-139]. (2020) (1)
- [Idiopathic interstitial pneumonia: treatment]. (2006) (1)
- COVID-19 in Lymphangioleiomyomatosis (2021) (1)
- Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs) (2020) (1)
- Care Delivery Models and Interstitial Lung Disease: The Role of the Specialized Center. (2021) (1)
- A Rare Case of an Abdominal Aneurysm in a Patient with Lymphangioleiomyomatosis: A Case Report. (2019) (1)
- Monocyte count and decline in forced vital capacity (FVC) in patients with IPF (2020) (1)
- FRI0299 Pulmonary Arterial Hypertension in Idiopathic Inflammatory Myopathies: Data from The French Pulmonary Hypertension Registry and Review of The Literature (2016) (1)
- [Unusual pulmonary presentation of systemic Langerhans cell histiocytosis]. (2008) (1)
- Idiopathic Pulmonary Fibrosis: Hospital Disease Management and Associated Costs. (2015) (1)
- Screening for Pulmonary Arteriovenous Malformation (PAVM) in Hereditary Hemorrhagic Telagiectasia: Clinical Significance of Pulmonary Micronodules and/or Positive TTCE Without PAVM (2019) (1)
- Association between influenza vaccination and the occurrence of acute exacerbation in idiopathic pulmonary fibrosis (2020) (1)
- [Pulmonary hypertension in chronic respiratory diseases]. (2014) (1)
- [Diagnostic difficulties of chronic pulmonary berylliosis in France]. (2020) (1)
- Predictors of objective cough in patients with idiopathic pulmonary fibrosis (IPF) (2019) (1)
- Prolonged sirolimus therapy in advanced pulmonary lymphangioleiomyomatosis; a multicenter French experience (2012) (1)
- Syndrome de Churg et Strauss (2008) (1)
- Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers (2019) (1)
- [Evidence based respiratory medicine. 6th update workshop of SPLF March 30th, 2007. Interstitial lung diseases]. (2007) (1)
- [Interstitial lung disease in connective tissue diseases]. (2007) (1)
- SAT0157 NINTEDANIB DOSE ADJUSTMENTS AND ADVERSE EVENTS IN PATIENTS WITH PROGRESSIVE AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES IN THE INBUILD TRIAL (2020) (1)
- Follow‐up of two cases of suspected interstitial lung disease following severe COVID‐19 infection shows persistent changes in imaging and lung function (2021) (1)
- Effect of baseline statin use on benefit of nintedanib (2016) (1)
- Nintedanib Plus Sildenafil in Patients with IPF and Severely Impaired Gas Exchange: Subgroup Analysis by Presence of Emphysema (2019) (1)
- Clubbing, Arthralgia and a Large Intrathoracic Mass (2012) (1)
- Demographics and Baseline Characteristics of Patients with Idiopathic Pulmonary Fibrosis (IPF) in a Real-World Setting: Results of 847 Patients Enrolled in the Radico-ILD Cohort in France (2020) (1)
- Desquamative interstitial pneumonia: still orphan and not always benign (2020) (1)
- Pulmonary hypertension in lymphangioleiomyomatosis: Hemodynamic characteristics in a series of 20 patients (2011) (1)
- Natural history of idiopathic pulmonary fibrosis (IPF) associated with obstructive sleep apnea (OSA) with or without continuous positive airway pressure (CPAP) (2018) (1)
- 68 – Eosinophilic Lung Diseases (2016) (1)
- Patients’ and Healthcare Professionals’ Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey (2020) (1)
- Pooled analysis of data from the TOMORROW and INPULSIS® trials of nintedanib in IPF (2016) (1)
- Idiopathic pulmonary arterial hypertension in the elderly: Data from the French registry (2011) (1)
- mTOR inhibitors for the management of difficult lymphangioma in adults. (2019) (1)
- Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression (2018) (1)
- Adult pulmonary Langerhans cell histiocytosis (2019) (1)
- Effects of nintedanib on markers of epithelial damage in subjects with IPF: data from the INMARK trial (2020) (1)
- Expectations about treatment of idiopathic pulmonary fibrosis: Comparative survey of patients, carers and physicians (the RESPIR French survey). (2021) (1)
- Characteristics Of Severe Pulmonary Hypertension Associated With COPD In A French Multicenter Study (2016) (1)
- Persistent cardiac rhabdomyoma in an adult with tuberous sclerosis. (2012) (1)
- “Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.” Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown. Eur Respir Rev 2017; 26: 170050. (2018) (1)
- A Network Model of Combined Pulmonary Emphysema and Fibrosis: Effects of Gravity. (2009) (1)
- Initial combination of macitentan and tadalafil in newly diagnosed patients with pulmonary arterial hypertension (PAH): results from the OPTIMA study (2017) (1)
- Contents Vol. 79, 2010 (2010) (1)
- Pneumopathies à éosinophiles : diagnostic et prise en charge (2012) (1)
- European Respiratory Society International Congress 2021: highlights from best-abstract awardees (2022) (1)
- P046 Analyses of the relationship between ΔFVC, ΔDLco, ΔCPI, extent of fibrosis and extent of emphysema in patients with idiopathic pulmonary fibrosis (IPF) (2016) (1)
- [Diagnostic case: Erasmus syndrome associating silica exposure with silicosis and systemic sclerosis]. (1995) (1)
- Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension – clinical management (2013) (1)
- Interstitial Lung Disease Following COVID-19. (2021) (1)
- Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis. (2022) (1)
- Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis (2022) (1)
- Steroid alternatives for managing eosinophilic lung diseases (2021) (1)
- 12q13.12q13.13 microdeletion encompassing ACVRL1 and SCN8A genes: Clinical report of a new contiguous gene syndrome. (2019) (1)
- Idiopathic chronic obliterative bronchiolitis: a multicentric retrospective cohort (2021) (1)
- Poumon et vascularites (2015) (1)
- Treatment of pulmonary arterial hypertension in elderly and very elderly patients (2016) (1)
- Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort (2014) (1)
- Lymphangioleiomyomatosis in TOSCA - TuberOus SClerosis registry to increAse disease awareness (2014) (1)
- Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome (2021) (1)
- French recommendations for the diagnosis and management of lymphangioleiomyomatosis. (2023) (1)
- Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function (2020) (1)
- Subclinical venous access infection and clinical worsening in pulmonary arterial hypertension. (2017) (1)
- Pulmonary involvement in inflammatory myopathies (2019) (1)
- Current epoprostenol use in patients with severe pulmonary hypertension (PH): Data from the French PH registry (2011) (0)
- Anticorps monoclonaux et pneumopathies interstitielles (2009) (0)
- Comparison of Organizing Pneumonia to Fibroblastic Foci in Usual Interstitial Pneumonia (2012) (0)
- Rare airway diseases (2019) (0)
- French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes (2023) (0)
- Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration (2018) (0)
- Clinically relevant benefit of mepolizumab and benralizumab in asthma following EGPA in real-life settings (2022) (0)
- Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity (2018) (0)
- Traitement des pneumopathies interstitielles diffuses (2006) (0)
- Tools for diagnosis, clinical phenotypes and follow-up (2015) (0)
- Liver involvement in patients with telomere-related genes mutations: prevalence, clinical, radiological, pathological features, outcome and risk factors (2020) (0)
- A cohort of patients with a progressive fibrosing phenotype of interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF): the PROGRESS study (2020) (0)
- Hemodynamic Characteristics In 100 Patients With Precapillary Pulmonary Hypertension And Interstitial Lung Disease (2012) (0)
- Front & Back Matter (2016) (0)
- Autoantibodies are associated with disease progression of idiopathic pulmonary fibrosis. (2023) (0)
- Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the "HYPID" study (2013) (0)
- A single-centre retrospective study to phenotype unclassifiable interstitial lung disease (2020) (0)
- [Pulmonary hypertension and fibrosis]. (2014) (0)
- [Saddle nose deformity]. (2007) (0)
- Front & Back Matter (2015) (0)
- Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis. (2022) (0)
- Nocardia otitidiscaviarum Infection in an Immunocompetent Patient (2020) (0)
- [Systemic scleroderma with interstitial pneumonia]. (2008) (0)
- Whole lung lavage therapy (WLL) of pulmonary alveolar proteinosis (PAP): A global survey of current practices and procedures (2016) (0)
- Cancer incidence in incident patients with precapillary pulmonary hypertension. (2018) (0)
- Classification anatomo-clinique des pneumopathies interstitielles diffuses idiopathiques : synthèse et perspectives (2010) (0)
- TCR rearrangement in patients with eosinophilic lung disease (2011) (0)
- Does excluding subjects with features similar to IPF affect the results of the INBUILD trial of nintedanib? (2020) (0)
- Pulmonary Function inPatients Receiving Long-term Low-dose Methotrexate* (2015) (0)
- PRS78 Burden of Idiopathic Pulmonary Fibrosis (IPF) on Quality of Life (QOL), Work Productivity and Healthcare Use (2020) (0)
- Unusual Bilateral Acinar Nodules: Case for Diagnosis (2009) (0)
- Pulmonary arterial hypertension in idiopathic in fl ammatory myopathies Data from the French pulmonary hypertension registry and review of the literature (2016) (0)
- Interstitial Pneumonia With Autoimmune Features: An Update (2018) (0)
- Additional file 1: of Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures (2016) (0)
- [Diagnostic uncertainty, working diagnosis and progress of recommendations for pulmonary fibrosis]. (2018) (0)
- Treatment of Interstitial Lung Disease (2017) (0)
- Faculty Opinions recommendation of Lymphangioleiomyomatosis - a wolf in sheep's clothing. (2012) (0)
- Acknowledgement to the Reviewers (2006) (0)
- Perception of the caregivers of patients with idiopathic pulmonary fibrosis: results of the French national survey, RESPIR (2019) (0)
- From Cancer Mimicking Orphan Lung Disease to Orphan Thoracic Oncology (2015) (0)
- Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perception (2020) (0)
- Faculty Opinions recommendation of Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice. (2012) (0)
- Prognostic value of 6-Min Walk Test (6MWT) in Patients with non-Idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease (PF-ILD) (2021) (0)
- Acknowledgement to reviewers (2017) (0)
- [Wegener's granulomatosis]. (2000) (0)
- Burden of idiopathic pulmonary fibrosis (IPF) on quality of life (QoL), work productivity, and healthcare use (2020) (0)
- [Systemic sclerosis-related interstitial lung disease: Diagnostic and therapeutic strategy in the light of recent clinical trials]. (2022) (0)
- Diagnosis, treatment and attitudes about idiopathic pulmonary fibrosis in Latin American physicians (2016) (0)
- [Epstein-Barr virus associated pulmonary lymphoma in Sjögren's syndrome]. (2010) (0)
- PRS1 Systematic Literature Review of Treatments for Interstitial Lung Disease in Patients with a Progressive Fibrosing Phenotype (2020) (0)
- Acknowledgement to the Reviewers (2002) (0)
- [Updated indications and contraindications in 2022 for lung transplantation in France]. (2022) (0)
- Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study (2020) (0)
- Determinants and prognostic value of kidney disease in pulmonary arterial hypertension (2018) (0)
- [Etiological diagnosis of pulmonary hypertension: A cause of difficult diagnosis]. (2018) (0)
- The clinical relevance of anti-fibrillarin (anti U3-RNP) autoantibodies in systemic sclerosis Short title: Anti-fibrillarin in systemic sclerosis (2016) (0)
- A genetic landscape of familial predisposition to sarcoidosis identified by whole exome sequencing (2017) (0)
- A Narrative Review of Real-World Data on the Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (2023) (0)
- Gene Expression Profiling in Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Nintedanib and Sildenafil: Data from the INSTAGE Trial (2020) (0)
- Chapter 49 – Eosinophilic Lung Disease (2012) (0)
- Chapter 53 – Organizing Pneumonia (2008) (0)
- Faculty Opinions recommendation of Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. (2012) (0)
- Front & Back Matter (2016) (0)
- Safety and Efficacy of BI 1015550, a Preferential Inhibitor of Phosphodiesterase 4b, in Patients with Idiopathic Pulmonary Fibrosis: A Phase 2 Trial (2022) (0)
- Joint Annual Meeting of the Swiss Society for Allergology and Immunology and the Swiss Respiratory Society, Bern, April 17-19, 2013 (2013) (0)
- Acknowledgement to reviewers 2009 (2009) (0)
- Healthcare resource use and related costs in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis (2020) (0)
- Chapter 50 – Organizing Pneumonia (2012) (0)
- Faculty Opinions recommendation of Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. (2012) (0)
- Development of Pulmonary Arteriovenous Malformations and Occurrence of Neurological Complications in patients with Hereditary Haemorrhagic Telangiectasia with isolated micronodules and/or intrapulmonary shunt at first screening (2019) (0)
- Progressive pulmonary fibrosis: all roads lead to Rome (but not all at the same speed) (2022) (0)
- Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE) (2015) (0)
- Introduction (2019) (0)
- Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch (2014) (0)
- [Alpha1-antitrypsin deficiency: French guidelines… at last !] (2022) (0)
- P279 Reduction In Disease Progression With Nintedanib In The Inpulsis™ Trials (2014) (0)
- [Pulmonary hypertension in interstitial pneumopathies]. (2009) (0)
- Association between influenza vaccination and the occurrence of acute exacerbation inidiopathic pulmonary fibrosis (2021) (0)
- LUNG CANCER AND COMBINED PULMONARY FIBROSIS AND EMPHYSEMA SYNDROME IN WESTERN PATIENTS: A SERIES OF 47 PATIENTS (2013) (0)
- [Idiopathic pulmonary fibrosis: Update of French practical guidelines]. (2022) (0)
- Survey of Physician's Knowledge, Attitudes, and Practices Regarding Idiopathic Pulmonary Fibrosis in Turkey. (2020) (0)
- Faculty Opinions recommendation of Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. (2011) (0)
- Long-term outcomes in incident pulmonary arterial hypertension (PAH) patients initiated with triple combination therapy including parenteral prostacyclin (PGI2) (2020) (0)
- Contents Vol. 76, 2008 (2008) (0)
- [Opacities and intra-thoracic masses]. (2008) (0)
- Effects of Nintedanib in Subgroups Based on Combined Pulmonary Fibrosis and Emphysema (CPFE) Index at Baseline (2020) (0)
- Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer (2018) (0)
- Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE (2023) (0)
- Clinical and Imaging Characteristics of Subependymal Giant Cell Astrocytoma in Patients with Tuberous Sclerosis Complex included in TOSCA – TuberOus SClerosis Registry to IncreAse Disease Awareness (2018) (0)
- Embolization of Recurrent Pulmonary Arteriovenous Malformations by Ethylene Vinyl Alcohol Copolymer (Onyx®) in Hereditary Hemorrhagic Telangiectasia: Safety and Efficacy (2022) (0)
- Reply: The ATS/JRS Guidelines on Lymphangioleiomyomatosis: Filling in the Gaps. (2017) (0)
- Idiopathic pulmonary fibrosis (IPF): the patient journey (2020) (0)
- [Evidence based respiratory medicine. 6th update workshop of SPLF March 30th, 2007. Pulmonary sarcoidosis]. (2007) (0)
- Gene Expression Profiling in Patients with Idiopathic Pulmonary Fibrosis (IPF) in the INMARK Trial (2020) (0)
- Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups (2016) (0)
- [Clinical pathologic classification of idiopathic interstitial pneumonia: review and perspectives]. (2010) (0)
- Pirfenidone in Unclassifiable Interstitial Lung Disease (uILD): A Subgroup Analysis Stratified by Concomitant Mycophenolate Mofetil (MMF) Use (2020) (0)
- Eosinophilic interstitial lung disorders (2017) (0)
- Subject Index Vol. 79, 2010 (2010) (0)
- Detecting early myocardial involvement in systemic sclerosis using cardiac magnetic resonance T1 mapping and speckle tracking echocardiography in correlation with plasma concentration of C-terminal pro-endothelin-1 (2013) (0)
- Lung function and exercise capacity profile in pleuroparenchymal fibroelastosis (2022) (0)
- [Rare pulmonary diseases: from the adoption of orphan diseases to structured healthcare networks]. (2014) (0)
- Progressive pulmonary fibrosis: an expert group consensus statement (2022) (0)
- Hospital costs of Balloon Pulmonary Angioplasty (BPA) procedure and management for CTEPH patients: An observational study based on the French national hospital discharge database (PMSI) (2021) (0)
- Small Airways in Pulmonary Fibrosis: Revisiting an Old Question with New Tools. (2022) (0)
- Front & Back Matter (2015) (0)
- Characteristics and management of patients with idiopathic pulmonary fibrosis treated with pirfenidone capsule or tablet formulation (2020) (0)
- “Idiopathic inflammatory myopathies and the lung.” Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216–238. (2015) (0)
- PCV25 Hospital Costs of Balloon Pulmonary Angioplasty (BPA) Procedure and Management for Chronic Thromboembolic Hypertension Patients: An Observational Study Based on the French National Hospital Discharge Database (PMSI) (2020) (0)
- Radionuclide Angiographic Assessment of Right Ventricular Ejection Fraction Is Pronostic in Pulmonary Arterial Hypertension (2013) (0)
- Pulmonary Arteriovenous Malformation After Metastatic Gestational Trophoblastic Tumor. (2019) (0)
- [French recommendations for idiopathic pulmonary fibrosis: An updated working document for clinicians]. (2017) (0)
- Pirfenidone in unclassifiable ILD (uILD): subgroup analysis of patients with/without a surgical lung biopsy (SLB) (2020) (0)
- Syndrome emphysème-fibrose (2016) (0)
- Recombinant human pentraxin-2 for idiopathic pulmonary fibrosis: Design of STARSCAPE-OLE, a Phase III open label extension study (2021) (0)
- The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) (2014) (0)
- PRS12 - DEVELOPMENT AND VALIDATION OF AN ALGORITHM IDENTIFYING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN HOSPITAL DISCHARGE DATABASES (2018) (0)
- To the Editors (2009) (0)
- [Base pulmonary fibrosis associated with summit emphysema: a new clinical entity?]. (2004) (0)
- Of fi cial American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management (2016) (0)
- Tuberous Sclerosis Complex (TSC) - Associated Epilepsy: Final Results from the TOSCA Study (2018) (0)
- Illicit drug use and pulmonary arterial hypertension: Not so frequent (2016) (0)
- Molecular endpoints for establishing target engagement by novel idiopathic pulmonary fibrosis therapies (2019) (0)
- Expectations of patients suffering from idiopathic pulmonary fibrosis about their treatment: results of the French national survey, RESPIR (2019) (0)
- [JSRV (jaagsiekte sheep retrovirus) and ovine pulmonary carcinoma]. (2006) (0)
- C URRENT OPINION Combined pulmonary fibrosis and emphysema in connective tissue disease (2012) (0)
- Eosinphilic granulomatosis with polyangiitis (2019) (0)
- Evaluation of Efficacy and Safety of Rituximab in Hypersensitivity Pneumonitis (HP) Patients: A Retrospective Observational Study (2020) (0)
- Criteria for Progressive Pulmonary Fibrosis: Getting the Horse Ready for the Cart (2022) (0)
- Isolated lymphocytic bronchiolitis with B cell clonality: Diagnosis in 3 cases using immunoglobulin gene rearrangement analysis (2012) (0)
- 2022 Update of indications and contraindications for lung transplantation in France. (2022) (0)
- [Interstitial lung disease]. (2017) (0)
- Contents Vol. 85, 2013 (2013) (0)
- Hemodynamics and response to therapy of pulmonary hypertension in patients with interstitial lung disease: Preliminary results of the "HYPID" prospective study (2012) (0)
- Contents Vol. 93, 2017 (2017) (0)
- Role of the occupational disease consultant in the multidisciplinary discussion of interstitial lung diseases (2022) (0)
- [3rd French day of idiopathic pulmonary fibrosis. September 19, 2014]. (2015) (0)
- Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) for Idiopathic Pulmonary Fibrosis: Study Design of STARSCAPE, A Phase III Randomized Double Blind Placebo Controlled Trial (2021) (0)
- [Diffuse interstitial pneumonia. Etiology and diagnosis]. (2001) (0)
- Eosinophilic Lung Diseases. (2023) (0)
- [Pulmonary MALT lymphoma]. (2007) (0)
- Effect of Nintedanib on FVC Decline in Patients with Progressive Fibrosing ILDs: Data from the INBUILD Trial (2020) (0)
- P-457 Incidence and pronostic implications of anti-Hu antibodies in patients with small cell lung cancer (2003) (0)
- Nemaline myopathy revealed by respiratory failure in adults (2007) (0)
- The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases (2019) (0)
- Phenotype and outcome of PAH patients carrying a TBX4 mutation (2020) (0)
- [Hypereosinophilic asthma]. (2011) (0)
- Thoracic manifestations of segmental neurofibromatosis (2017) (0)
- Front & Back Matter (2012) (0)
- Analysis of baseline characteristics by emphysema extent in patients with idiopathic pulmonary fibrosis (IPF) (2017) (0)
- “Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty.” Vincent Cottin. Eur Respir J 2016; 48: 1274–1277. (2016) (0)
- A Cohort of Patients with a Progressive Fibrosing Phenotype of Interstitial Lung Disease (PF-ILD) Other Than Idiopathic Pulmonary Fibrosis: The Progress Study (2020) (0)
- Presenting the Board of Respiration: Vincent Cottin (2020) (0)
- New therapeutic strategies in lung vasculitis: Current Opinion in Pulmonary Medicine, invited review. (2020) (0)
- Precapillary Pulmonary Hypertension With Pulmonary Vessel Involvement In Lymphangioleiomyomatosis (2012) (0)
- Front & Back Matter (2012) (0)
- Identifying Opportunities for Earlier IPF Diagnosis (2018) (0)
- Decline in Forced Vital Capacity (FVC) in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in Consecutive 6-Month Periods of the SENSCIS Trial (2022) (0)
- Smoking-Related—Interstitial Lung Disease (2020) (0)
- Tracheobronchial stenoses (TBS) in granulomatosis with polyangiitis (Wegener) (GPA) (2013) (0)
- Prognostic value of changes in radionuclide right ventricular ejection fraction in pulmonary arterial hypertension (2013) (0)
- Iconography : Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report (2009) (0)
- The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease (2012) (0)
- [Alveolar haemorrhage in leptospirosis]. (2008) (0)
- Pneumopathie interstitielle diffuse inclassable : une entité distincte à progression hétérogène (2019) (0)
- Interstitial lung diseases associated with amyopathic dermatomyositis. Commentary (2006) (0)
- Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease. (2022) (0)
- Effect of nintedanib on biomarkers of extracellular matrix (ECM) turnover and FVC decline in patients with IPF: results from the INMARK study* (2019) (0)
- Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD Cohort (2021) (0)
- Screening for pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia in the French national reference centre (2018) (0)
- Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: a multicentric retrospective cohort study (2020) (0)
- Faculty Opinions recommendation of Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis. (2011) (0)
- Correlation between alveolar-arterial oxygen tension difference (AaPO2) on room air and while breathing 100% O2 : implications for screening for shunting (2019) (0)
- 1225 Post-systolic shortening: a marker of severity in patients with severe pulmonary hypertension (2006) (0)
- Changes in biomarkers with nintedanib plus sildenafil in subjects with IPF by presence of emphysema in the INSTAGE trial (2020) (0)
- Bronchiolite lymphocytaire clonale B isolée : diagnostic par analyse de réarrangement génique (2013) (0)
- [Idiopathic pulmonary fibrosis]. (2014) (0)
- [Connective tissue disease and the lung]. (2011) (0)
- Nationwide survey of physicians' attitude and approach to the clinical evaluation of interstitial lung disease in Singapore (2018) (0)
- 558 INTRODUCTION Definition Eosinophilic lung diseases (2012) (0)
- Phase II Trial of Voriconazole (VORI) for Proven Chronic Pulmonary Aspergillosis. (2009) (0)
- Chapter 52 – Eosinophilic Lung Disease (2008) (0)
- [French clinical practice guidelines for the diagnosis and management of lung disease with alpha 1-antitrypsin deficiency]. (2022) (0)
- [Pulmonary alveolar proteinosis]. (2005) (0)
- Pulmonary hypertension in hereditary hemorrhagic telangiectasia is associated with multiple clinical conditions (2019) (0)
- Differences in the Approach to Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE IPF) Between Expert Centres and General Pulmonologists: Results from an International Survey (2019) (0)
- Outcomes in Patients Receiving Nintedanib or Pirfenidone for Idiopathic Pulmonary Fibrosis (2020) (0)
- Safety and Tolerability of Nintedanib in Patients with Fibrosing ILDs: A Comparison of the INBUILD and INPULSIS Trials (2020) (0)
- [Pulmonary hypertension in interstitial lung diseases: diagnostic and therapeutic approach in 2011?]. (2011) (0)
- [Imaging of bronchiolitis]. (2002) (0)
- Faculty Opinions recommendation of Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis. (2012) (0)
- [Your images. Bone sarcoidosis]. (2010) (0)
- Study Design and Rationale for the TETON Phase 3 Clinical Trials of Inhaled Treprostinil in the Treatment of Idiopathic Pulmonary Fibrosis (2022) (0)
- [Chronic necrotizing aspergillosis]. (2008) (0)
- Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France (2020) (0)
- [A special micronodular lung disease]. (2020) (0)
- Eosinophilic Pneumonia (2014) (0)
- [Pulmonary rheumatoid nodule]. (2007) (0)
- In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicenter study. (2023) (0)
- Front & Back Matter (2012) (0)
- Diagnosis, management and attitudes about idiopathic pulmonary fibrosis among Turkish pulmonologists (2019) (0)
- Lung function in Birt-Hogg-Dubé syndrome (2017) (0)
- Decrease Of Mean Pulmonary Artery Pressure Under 100% Inspired Oxygen In Patients With Precapillary Pulmonary Hypertension (2010) (0)
- Treatment of interleukin-2-induced thrombocytopenia by intravenous immunoglobulin. (1994) (0)
- The European Respiratory Review: meeting expectations of respiratory physicians through diversity and quality (2014) (0)
- [Progress in the diagnosis of organising pneumonia]. (2008) (0)
- Ethnographic survey of patients and caregiver's life journey in idiopathic pulmonary fibrosis. (2022) (0)
- Lung Dual-Energy CT Perfusion Blood Volume as a Marker of Severity in Chronic Thromboembolic Pulmonary Hypertension (2023) (0)
- [Idiopathic pulmonary fibrosis: A new era, new challenges]. (2014) (0)
- Low income and progression free survival in idiopathic pulmonary fibrosis: An association to uncover (2020) (0)
- Severe pulmonary hypertension associated with COPD: long-term results of a prospective French multicentre cohort (2022) (0)
- Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON (2021) (0)
- Contents Vol. 94, 2017 (2017) (0)
- Faculty Opinions recommendation of Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. (2012) (0)
- Faculty Opinions recommendation of Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. (2009) (0)
- Death Domain CD120a to Lipid Rafts: A Novel Role for the Restricted Localization of the TNF Receptor (2013) (0)
- Inhaled Treprostinil in Group 3 Pulmonary Hypertension. (2021) (0)
- Comparison of pulmonary function tests (PFTs) and 6-minute walk test (6MWT) in patients with lymphangioleiomyomatosis (LAM) (2020) (0)
- Analyses of the relationship between ΔFVC, extent of fibrosis and extent of emphysema in patients with idiopathic pulmonary fibrosis (IPF) (2016) (0)
- PRS11 Healthcare Resource Utilization and Associated Costs of Progressive Fibrosing Interstitial LUNG Disease (PF-ILD) and Systemic Sclerosis Associated Interstitial LUNG Disease (SSC-ILD) in France. (2020) (0)
- Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project (2020) (0)
- Rate of FEV1 decline in lymphangioleiomyomatosis associated with tuberous sclerosis complex (2012) (0)
- A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia (2015) (0)
- Front & Back Matter (2016) (0)
- THU0106 Identification of Markers Associated with The Occurrence of Interstitial Lung Disease in Rheumatoid Arthritis Patients (2016) (0)
- Supplementary Material for: Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis (2018) (0)
- Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the "HYPID" prospective study (2013) (0)
- [Diffuse pulmonary diseases]. (2002) (0)
- Isolated Recurrent Pleuritis Revealing Familial Mediterranean Fever in Adulthood (2010) (0)
- Iconography : Pneumopathies à éosinophiles : diagnostic et prise en charge (2012) (0)
- Subject Index Vol. 76, 2008 (2008) (0)
- Acknowledgement to reviewers 2009 (2010) (0)
- Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI) (2018) (0)
- [Acute and chronic chest pain]. (2002) (0)
- French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length version. (2022) (0)
- [Lung transplantation for scleroderma lung disease]. (2023) (0)
- Subacute Exacerbation of Idiopathic Pulmonary Fibrosis: Incidence, Characteristics and Outcomes (2019) (0)
- Diagnostic étiologique de l’hypertension pulmonaire : une cause de diagnostic difficile (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Vincent Cottin?
Vincent Cottin is affiliated with the following schools:
